About Ubithera Pharma Private Limited
Data last updated:
Ubithera Pharma Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Ubithera Sarl. It operates in the business support services segment of the business services sector. It was incorporated on 12 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC275235. Its GSTIN is 07AABCU7754R1ZH (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Traore Hamidou and Ingani Hyacinthe.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.230 Third Floor Doon Building Block A – 2 Sector – 17 Dwarka, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹11.08 Lakh (net margin 9.2%) and EBITDA of ₹17.62 Lakh (EBITDA margin 14.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ubithera.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.230 Third Floor Doon Building Block A – 2 Sector – 17 Dwarka, New Delhi, Delhi, India – 110078
- IndustryBusiness Services, Business Support Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ubithera Pharma Private Limited
The main business activity of Ubithera Pharma is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ubithera Pharma Private Limited FY 2025 filings available
Ubithera Pharma Private Limited reported revenue of ₹1.21 Cr (up 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ubithera Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 27% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ubithera Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.62 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.08 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ubithera Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ubithera Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ubithera Pharma Private Limited
Ubithera Pharma Private Limited is compared with the companies closest to it by revenue in the Business Services industry (Business Auxiliary Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RKHS Food and Allied Services Private Limited | ₹1.22 Cr (FY 2019) | •••• | •••• | 7224.0% | •••• | Mumbai, Maharashtra, India |
| Salvus Technologies Private Limited | ₹1.22 Cr (FY 2024) | •••• | •••• | 101.0% | •••• | Pune, Maharashtra, India |
| Upswings Educare Private Limited | ₹1.22 Cr (FY 2024) | •••• | •••• | 1640.0% | •••• | Coimbatore, Tamil Nadu, India |
| Medrina Technology Management Private Limited | ₹1.21 Cr (FY 2021) | •••• | •••• | -27.0% | •••• | New Delhi, Delhi, India |
| Armaco Logistics Private Limited | ₹1.21 Cr (FY 2025) | •••• | •••• | -65.0% | •••• | Chandrapur, Maharashtra, India |
| Ubithera Pharma Private Limited this company | ₹1.21 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | New Delhi, Delhi, India |
| Finvin Turnaround and Restructuring Private Limited | ₹1.21 Cr (FY 2025) | •••• | •••• | 273.0% | •••• | Mumbai, Maharashtra, India |
| Neoripples Private Limited | ₹1.2 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Gurugram, Haryana, India |
| Vital Radiology Services Private Limited | ₹1.2 Cr (FY 2022) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Taffles Exports Private Limited | ₹1.2 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Navunnaati Business Private Limited | ₹1.2 Cr (FY 2024) | •••• | •••• | 405.0% | •••• | Gurgaon, Haryana, India |
Peers are the five companies nearest above and the five nearest below Ubithera Pharma by revenue in the Business Services industry (Business Auxiliary Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ubithera Pharma Private Limited
Ubithera Pharma Private Limited is audited by G S S V & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G S S V & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ubithera Pharma Private Limited
Ubithera Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Traore Hamidou | Director | 12 Jan 2015 | 11 Years 8 Months | Current |
| Ingani Hyacinthe | Director | 12 Jan 2015 | 11 Years 8 Months | Current |
| Mohd Rashid Ahmad | Director | 13 Feb 2015 | 11 Years 7 Months | Current |
Ownership and Shareholding of Ubithera Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ubithera Pharma Private Limited
Ubithera Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ubithera Pharma Private Limited
Employment history and EPFO contributions of people linked to Ubithera Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ubithera Pharma Private Limited
Ubithera Pharma Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Parminder Singh ceased to be Director on 16 Feb 2015.
Credit Ratings, Litigation & Regulatory Alerts for Ubithera Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ubithera Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ubithera Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ubithera Pharma Private Limited
Ubithera Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCU7754R1ZH | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ubithera Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ubithera Pharma Private Limited
Ubithera Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in business support services, within the business services industry. It was incorporated on 12 January 2015 (11+ years old) and is registered under CIN U24100DL2015PTC275235.
Ubithera Pharma reported revenue of ₹1.21 Cr for FY 2025 (up 27% YoY).
Ubithera Pharma has 3 current directors:
- Traore Hamidou - Director
- Ingani Hyacinthe - Director
- Mohd Rashid Ahmad - Director
Ubithera Pharma reported a net profit of ₹11.08 Lakh (net margin 9.2%) and EBITDA of ₹17.62 Lakh (EBITDA margin 14.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ubithera Pharma is 14% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 27%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ubithera Pharma is 07AABCU7754R1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Ubithera Pharma is U24100DL2015PTC275235. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ubithera Pharma was incorporated on 12 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ubithera Pharma by revenue are RKHS Food and Allied Services Private Limited, Salvus Technologies Private Limited, Upswings Educare Private Limited, Medrina Technology Management Private Limited, Armaco Logistics Private Limited and 5 more, all in the Business Services industry (Business Auxiliary Services).
Parminder Singh ceased to be Director on 16 Feb 2015. Mohd Rashid Ahmad was appointed as Director on 13 Feb 2015. Ingani Hyacinthe was appointed as Director on 12 Jan 2015. Ubithera Pharma has 4 board changes on record in total.
Ubithera Pharma can be reached through the website ubithera.com. Its registered office is in New Delhi, Delhi, India.